A Comparative Study of Molecular Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Antiplatelet Drugs-Reference-Cited by-同舟云学术

A Comparative Study of Molecular Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Antiplatelet Drugs

Published:2016-03-19 Issue:3 Volume:17 Page:388
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Remko Milan,Remková Anna,Broer Ria^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/3/388/pdf

Reference63 articles.

1. Heart Disease and Stroke Statistics—2007 Update

2. Antiplatelet therapies for the treatment of cardiovascular disease

3. Antiplatelet therapy: new pharmacological agents and changing paradigms

4. Platelet Activation and Atherothrombosis

5. Advances in Antiplatelet Therapy: Agents in Clinical Development

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Eutectic Solvent (DES)‐Mediated Green Approach for Synthesis of Benzothiazole Tethered Pyrazoles: Antimicrobial Properties and Molecular Docking Insights;ChemistrySelect;2024-08-22

2. The Determination of LogP of Anticoagulant Drugs with High-Performance Thin-Layer Chromatography;Processes;2024-07-30

3. HPLC Method Development and Validation for the Determination of Apixaban and Clopidogrel in Novel Fixed-Dose Combination Tablets;Journal of Chemistry;2024-01-25

4. Ultrasonic-Assisted Synthesis of Heterocyclic Curcumin Analogs as Antidiabetic, Antibacterial, and Antioxidant Agents Combined with in vitro and in silico Studies;Advances and Applications in Bioinformatics and Chemistry;2023-07

5. Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes;Vascular Pharmacology;2023-04